1Malhotra HS,Goa KL.Atorvastatin:an updated review of its pharmacological properties and use in dyslipidaemia[J].Drugs,2001,61(12):1 835.
2Yusuf S,Zhao F,Mehta SR,et al.Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J].N Engl J Med,2001,345(7):494.
3Pereillo JM,Uzabiaga MF,Combalbert J,et al.Identification and biological activity of the active metabolite of clopidogrel[J].Thromb Haemost,2000,84(5):891.
4Savi P,Combalbert J,Gaich C,et al.The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A[J].Thromb Haemost,1994,72(2):313.
5Savi P,Pereillo JM,Uzabiaga MF,et al.Herbert JM.Identification and biological activity of the active metabolite of clopidogrel[J].Thromb Haemost,2000,84(5):891.
6Clarke TA,Waskell LA.The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatinp[J].Drug Metab Dispos,2003,31(1):53.
7Lau WC,Waskell LA,Watkins PB,et al.Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation:a new drug-drug interaction[J].Circulation,2003,107(1):32.
8Neubauer H,Gunesdogan B,Hanefeld C,et al.Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function-a flow cytometry study[J].Eur Heart J,2003,24(19):1 744.
9Serebruany VL,Malinin AL,Callahan KP,et al.Statins do not affect platelet inhibition with clopidogrel during coronary stenting[J].Atherosclerosis,2001,159(1):239.
10CAPRIE Steering Committee.A randomised,blinded,trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)[J].Lancet,1996,348(9 038):1 329.
